Tag Archives: DCGI

India is likely to get a coronavirus disease (Covid-19) vaccine in the New Year, the country’s top drug regulator hinted during a webinar on the science behind the vaccine’s development that allowed it to arrive from the lab. to people in less than 12 months. “We will have a Happy …

With preparations underway for a possible launch of the vaccine in January, India’s drug regulator is looking to the UK, which sources say may give Oxford its go-ahead. COVID-19 vaccine next week, before deciding to give emergency use authorization to the Serum Institute that makes the injections here. Once the …

NEW DELHI: A committee of experts from the Central Standard Medicines Control Organization (CDSCO) will meet on Wednesday to review applications from Pfizer, Serum Institute of India and Bharat Biotech seeking emergency use authorization for their vaccine candidates Covid-19, official sources said Monday. night. The decision was made late Monday …

A senior Health Ministry official told The Hindu that Covishield is logistically more feasible for use and distribution in India, as it stores well between two and eight degrees Celsius. The Serum Institute of India (SII) said on Monday that it had applied to the Controller General of Drugs of …

Coronavirus News LIVE Updates: The Serum Institute of India became the first indigenous company on Sunday to apply to the Controller General of Drugs of India (DCGI) seeking an emergency use authorization for Oxford COVID-19 vaccine in the country citing unmet medical needs due to the pandemic and in the …

NEW DELHI: The Serum Institute of India on Sunday became the first indigenous company to submit an application to the Comptroller General of Drugs of India (DCGI) seeking an emergency use authorization for the Oxford Covid-19 vaccine in the citing unmet medical needs due to the pandemic and in the …

New Delhi: Pfizer India has become the first pharmaceutical company to apply to the Controller General of Drugs of India (DCGI) for an emergency use authorization for its COVID-19 vaccine in the country, after its parent company obtained such authorization in the UK and Bahrain. The firm, in its request …

India’s first coronavirus disease (Covid-19) candidate vaccine, Covaxin, which is being developed by Bharat Biotech, is likely to be at least 60% effective. On Thursday evening, the company received approval from the Controller General of Medicines of India (DCGI) to conduct a phase 3 clinical trial to establish the efficacy …

NEW DELHI: India’s Comptroller General of Drugs approved the commercial launch of ‘Feluda’, the Tata CRISPR (regularly interspaced regularly clustered short palindromic repeats) Covid-19 test, the Council for Scientific and Industrial Research (CSIR) said on Saturday. This test uses state-of-the-art CRISPR technology developed in the country for the detection of …

Dr VG Somani of the Comptroller General of Drugs of India (DCGI) has given the Serum Institute of India (SII) permission to resume the clinical trial of the Oxford Covid-19 candidate vaccine in the country, while also revoking your previous order to suspend any new recruitment for phase two and …